Dorissa Rawls
Hematology & Oncology · Atlanta, GANPI 1447761655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $670 and has fallen 87.3% since, to $85 in 2025. That places this record below the midpoint for hematology & oncology clinicians in GA, where the typical reported total is $4,479.
Across 91 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$474
- E.r. Squibb & Sons, L.L.C.$314
- Johnson & Johnson$140
- Incyte Corporation$128
- Pharmacyclics LLC, An Abbvie Company$123
- AbbVie$115
- plus $781 from 20 others
What the payments were for
- Food & beverage$2,075100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 23 | $474 |
| E.r. Squibb & Sons, L.L.C. | 3 | $314 |
| Johnson & Johnson | 7 | $140 |
| Incyte Corporation | 7 | $128 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $123 |
| AbbVie | 5 | $115 |
| Amgen | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Gilead | 4 | $68 |
| Jazz Pharmaceuticals Inc. | 3 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Karyopharm Therapeutics Inc. | 3 | $52 |
| Seagen Inc. | 3 | $44 |
| Beigene USA, Inc. | 2 | $42 |
| ADC Therapeutics America, Inc. | 2 | $42 |
| Morphosys, US Inc. | 2 | $33 |
| Merck | 1 | $31 |
| GSK | 2 | $29 |
| Novartis | 1 | $28 |
| Legend Biotech USA Inc. | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $22 |
| Sobi, Inc | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pomalyst$126
How this compares
$2,075 in reported general payments places this provider in the 35th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Atlanta
- Ticiana LealAtlanta$450K
- Ajay NookaAtlanta$222K
- Rodolfo BordoniAtlanta$159K
- Mehmet BilenAtlanta$150K
- Olatunji AleseAtlanta$137K
- Gina D AmatoAtlanta$97K
- Otis BrawleyAtlanta$89K
- Conor SteuerAtlanta$86K
- Fuad El RassiAtlanta$84K
- Jonathon CohenAtlanta$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.